Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Craniofac Surg ; 33(7): 2028-2030, 2022 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-35045013

RESUMEN

BACKGROUND: Chronic refractory wounds were common and the treatments were complicated for burn and plastic surgeons. This study was to investigate the bacterial distribution characteristics and bacterial drug resistance of chronic refractory wound secretions. METHODS: The authors retrospectively analyzed 425 patients with chronic refractory wound infection. The results of bacterial culture of wound secretions and drug sensitivity test were retrospectively analyzed. Further, the location area of the wound was divided into 4 regions, and the difference of the bacterial culture results between different regions was analyzed. RESULTS: The wound secretions were cultured into 401 bacterial strains, including 206 gram-positive bacteria strains, accounting for 51.4%, with the highest detection rate of Staphylococcus aureus at 26.2% (105/401). There were 195 gram-negative bacteria strains, accounting for 48.6%, with the highest detection rate of Pseudomonas aeruginosa at 14.2% (57/401). There were 6 fungal strains. The proportion of gram-negative bacteria in the III region of the wound zone was significantly greater than that in the other 3 regions. CONCLUSIONS: The detection rate of gram-positive bacteria and gram-negative bacteria of chronic refractory wound secretions is not much different. However, in the area close to the perineum (III region), gram-negative bacteria is significantly higher, which has a certain reference value for the use of antibiotics in clinical practice. LEVEL OF EVIDENCE: Level 4.


Asunto(s)
Quemaduras , Bacterias Gramnegativas , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Quemaduras/complicaciones , Farmacorresistencia Bacteriana , Bacterias Grampositivas , Humanos , Pruebas de Sensibilidad Microbiana , Estudios Retrospectivos
2.
J Pediatr Endocrinol Metab ; 36(5): 484-491, 2023 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-36935568

RESUMEN

OBJECTIVES: Childhood-onset craniopharyngiomas (CPs) have a high incidence of growth hormone deficiency (GHD) leading to growth failure and metabolic disorders. We aim to evaluate the benefits and risks of recombinant human growth hormone replacement therapy (GHRT) in postoperative children. METHODS: We retrospectively analyzed auxological and metabolic parameters and adverse events before and after GHRT of 44 children after CP surgery. RESULTS: The median duration of GHRT was 24 months (IQR, 12.5-36). Growth velocity (GV) increased significantly after different treatment duration (TD) compared with baseline (p<0.001) and attained the greatest GV of 12.06 ± 4.16 cm/year at TD6. The mean height standard deviation score (HtSDS) from -3.20 ± 1.16 at baseline improved significantly to -1.51 ± 1.32 at TD36 (p<0.001). There were significant increases in insulin-like growth factor-1 SDS (IGF-1SDS), insulin-like growth factor binding protein 3 SDS (IGFBP-3SDS), bone age (BA), and BA/chronological age (CA) (p<0.05). There was a significant reduction in waist-to-hip ratio (WHR), but there were no significant changes in weight SDS (WtSDS) or BMISDS. Low-density lipoprotein-cholesterol (LDL-C) levels and the incidence of hypercholesterolemia decreased (p<0.05). Three patients (6.8%) had tumor recurrence after 15, 30, and 42 months, respectively. A patient had residual tumor enlargement after 3 months. There was no adverse influence on glucose metabolism or any severe adverse events. CONCLUSIONS: GHRT effectively accelerates GV, increases HtSDS, and improves lipid profiles without unfavorable effects on glucose metabolism. The benefits are clear and the risks of adverse events are low.


Asunto(s)
Craneofaringioma , Enanismo Hipofisario , Hormona de Crecimiento Humana , Hipopituitarismo , Neoplasias Hipofisarias , Humanos , Niño , Estudios Retrospectivos , Recurrencia Local de Neoplasia , Enanismo Hipofisario/tratamiento farmacológico , Hipopituitarismo/tratamiento farmacológico , Hormona del Crecimiento/uso terapéutico , Factor I del Crecimiento Similar a la Insulina/metabolismo , Terapia de Reemplazo de Hormonas , Medición de Riesgo , Glucosa/uso terapéutico , Trastornos del Crecimiento/tratamiento farmacológico
3.
Zhong Yao Cai ; 33(7): 1038-41, 2010 Jul.
Artículo en Zh | MEDLINE | ID: mdl-21137357

RESUMEN

OBJECTIVE: To solve the puzzle about the right size of the explant of wild medicinal plant Lycoris aurea for tissue culture. METHODS: Three-size explants: 9.0 x 8.0 mm, 6.0 x 5.0 mm, 3.0 x 2.0 mm of endothecium bulb-scale joined by a strip of stem plate and middle-layer bulb-scale joined by a strip of stem plate were cultured on two kinds of the medium: MS +9 mg/L BA +5 mg/ L NAA +0.7% agar +3% cane sugar and MS +5 mg/L BA +9 mg/L NAA +0.7% agar +3% cane sugar, and the culture effects of the three-size explants for Lycoris aurea were studied. RESULTS AND CONCLUSION: The results showed that the explant size on 6.0 x 5.0 mm of the endothecium bulb-scale cultured on the medium: MS +9 mg/L BA +5 mg/L NAA +0.7% agar +3% cane sugar had the advantage of forming adventitious buds and roots, and inhibiting brown samples, and to the middle-layer bulb-scale explant of the same size cultured on the same medium was next. Correlation analysis showed that the culture effect of the three-size explants on one kind of medium was significantly correlated with that of theirs on another kind of medium, which further proved that the result of Duncans multiple range test, i.e. if the effect of an explant size on one kind of medium were better, its effect on another kind of medium would also be better. Both Duncan's multiple range test and correlation analysis indicated that the effect of the size on 6.0 x 5.0 mm explant of the double endothecium bulb-scale joined by a strip of stem plate was better than those of the other sizes on the experimental explants, and to that of 6.0 x 5.0 mm size of the double middle-layer bulb-scale joined by a strip of stem plate was next.


Asunto(s)
Lycoris/crecimiento & desarrollo , Raíces de Plantas/crecimiento & desarrollo , Técnicas de Cultivo de Tejidos/métodos , Medios de Cultivo/metabolismo , Reguladores del Crecimiento de las Plantas/metabolismo , Regeneración/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA